Page 4 of pharmaceutical

Sahasra Electronic Solutions Ltd, Service Care Ltd, Infinium Pharmachem Ltd, GHCL Ltd

5 stocks Warren Buffetts of India just added to their portfolios

The super investors of India or like we call them, the Warren Buffetts of India, have made some big changes…

April 25, 2025 05:30 IST

Protean eGov Technologies share price, PAN 2.0 project

Syngene International shares plummet 13%: Here’s what’s worrying investors

Syngene share price today, April 24: Syngene’s stock drops 13% due to 8% Q4 profit decline. Explore insights into their…

April 24, 2025 14:22 IST

Donald Trump, reciprocal tariff, exports, imports, global markets, Indian market, China, trade deficits, manufacturing, investment, GDP, pharmaceuticals, auto sector, retail investors

India may gain in short-term from Trump’s 90-day tariff break but uncertainty persists, says Kotak Securities

Trump’s 90 days tariff break, Kotak said, does not change the US’s goals, leading to continued large uncertainties for (1)…

Updated: April 15, 2025 16:51 IST

Trump announces ‘major tariff’ on pharmaceuticals soon, claims China is ‘manipulating currency’

White House Press Secretary Karoline Leavitt confirmed in a press briefing on Tuesday that the 104% tariff will take effect…

April 9, 2025 08:19 IST

Why is the market falling today? 4 reasons…

Global recession fears have spooked the indices and the markets are trending lower with massive selloff in pharma and metals…

Updated: April 4, 2025 15:10 IST

donald trump, reciprocal tariffs, us india trade, trade deficit, trade surplus, tariffs, liberation day,

Trump tariff to come into effect soon: Here’s what has unfolded till now and what can be expected

US President Trump is making last-minute decisions on his plans to impose reciprocal tariffs and his team is reportedly still…

April 2, 2025 15:23 IST

Trump says he’ll announce new pharmaceutical tariff soon

US President Donald Trump said that he is open to tariff negotiations after he announces reciprocal tariffs on April 2,…

Updated: March 29, 2025 07:44 IST

Three reasons why pharma stocks are falling today?

Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

Updated: March 25, 2025 14:45 IST

Trump signals auto tariffs in ‘near future’, might give breaks to ‘a lot of countries’ on April 2

Trump added that tariffs on lumber and semiconductor industries would also be introduced at a later time.

March 25, 2025 07:07 IST

Zydus Lifesciences share price today, March 13

16% cut in Zydus Lifesciences target: 4 big worries for Nuvama are…

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

March 13, 2025 09:53 IST

pharma sector, Jan Aushadhi, branded pharmaceutical market, volume growth, trade generics, pharmacy chains, acquisitions

India’s pharma industry betting big on CDMO opportunity – All you need to know

India’s Contract Development and Manufacturing Organization (CDMO) market is witnessing a strong growth trajectory driven by a confluence of factors,…

March 12, 2025 17:43 IST

Donald Trump, tariff, pharma sector, pharma companies, trade, export, import

Poverty of ambition: To thrive, Indian pharma needs R&D investment, not just tariff cuts

Zero tariffs for US drugs cost little but Indian firms must look beyond branded generics, seek R&D-driven growth.

March 11, 2025 06:00 IST

Jefferies bets big on these 3 pharma stocks- Find out why

Jefferies backs Lupin, Zydus, and Biocon amid shifting US pharma market shares. Discover why these stocks are set to shine.

March 4, 2025 14:31 IST

pharmaceuticals, pharma sector, US tariff, Donald Trump, exports, imports, US customers, price hike, competitiveness, Indian drugs, pricing erosion, US generics, formulations

Trump tariff unlikely to be a bitter pill for pharma – Everything you need to know

Kotak Institutional Equities analysed the base and worst case scenarios in the event of the tariff hike by the US…

February 28, 2025 15:18 IST

CRDMO sector, pharma sector, revenue growth, US tariff, capital expenditure, debt funding, credit profiles, USFDA, R&D, manufacturing

India becoming an attractive option for global pharmaceutical supply chain: Macquarie Report

The industry is projected to grow at a 14 per cent compound annual growth rate (CAGR), driven by rising pharmaceutical…

February 20, 2025 13:00 IST

Markets flat, Sensex swings 700 points, IT stocks shine

Pharma stocks are down as much as 10%. Read to know why…

Pharma stocks plummet up to 10% amid looming US tariffs. Discover the impact!

February 19, 2025 10:10 IST

Trump likely to impose 25% tariffs on imported automobiles, chips and pharmaceuticals

The initiative aims to boost domestic manufacturing and address what Trump views as unfair trade practices.

Updated: February 19, 2025 09:50 IST

Indian pharma industry, pharma, drugs, healthcare, health, IDMA

Indian pharma and the case for tempered take on tariff gains for US

While the US is a $600 billion pharmaceutical market, the share of these generic is 90 per cent in terms…

February 18, 2025 14:12 IST

Related News

Four big companies have now stopped sponsoring H-1B visas. Here is the full list

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar card update new rules from November 2025: You won’t need to upload documents anymore — here’s how to change your details online

Asia Cup Trophy Controversy: India refuses award, PCB proposes special handover

Asia Cup 2025 Trophy row: PCB chief Mohsin Naqvi sends firm message to BCCI, says ‘If you want the trophy, we…’

EB-5 fees, EB-5 filing fees cut, EB-5 visa, USCIS EB-5 rule, DHS EB-5 rule, Form I-526 fee reduction, Form I-829 petition, EB-5 investor program, EB-5 technology fee, EB-5 program changes

US cuts EB-5 fees for foreign investors seeking employment-based green cards

Jefferies buy recommendations, Jefferies stock picks India

3 ‘Buy’ recommendations by Jefferies, with up to 34% upside potential

GX Group to invest Rs 3,000 crore to build photonics chip ecosystem

Business29 min ago

Netherlands-based broadband company GX Group is investing Rs 3,000 crore in its new subsidiary, GX Quantum Photonics, to develop photonic chips and modules for 5G/6G, AI data centres, EV LiDAR, and quantum communication. Production will begin in FY27 and the venture is supported by Invest International and SMART Photonics BV.

View all shorts